Baseline expression of miRNAs in HER-2+ early breast cancer patients as a predictor of cancer therapy-related cardiac dysfunction
Int. j. cardiovasc. sci. (Impr.); 37 (suppl. 12), 2024
BACKGROUND: The classic biomarkers troponin and brain natriuretic peptide (BNP), as well as the currently available risk scores, are far from being considered ideal for predicting cancer therapy-related cardiac dysfunction (CTRCD). MicroRNAs (miRNAs) are promising biomarkers for better identification of ...